1.
Papp KA, Yeung J, Shear N, Albrecht L, Lynde C, Zhang J, Zhao Y, Parno J, Mendelsohn AM, Gooderham M. Early and Maintained Response Levels in Psoriasis Patients Treated with Tildrakizumab. J of Skin [Internet]. 2020Sep.2 [cited 2022Jul.1];4(5):s41. Available from: https://www.jofskin.org/index.php/skin/article/view/990